Stephen C Harward1, William C Chen2, John D Rolston2, Michael M Haglund1, Dario J Englot3. 1. Department of Neurosurgery, Duke University School of Medicine, Durham, North Carolina. 2. Department of Neuro-logical Surgery, University of California San Francisco, San Francisco, California. 3. Department of Neurological Surgery, Vanderbilt University Medical Center, Nashville, Tennessee.
Abstract
BACKGROUND: Occipital lobe epilepsy (OLE) is an uncommon but debilitating focal epilepsy syndrome with seizures often refractory to medical management. While surgical resection has proven a viable treatment, previous studies examining postoperative seizure freedom rates are limited by small sample size and patient heterogeneity, thus exhibiting significant variability in their results. OBJECTIVE: To review the medical literature on OLE so as to investigate rates and predictors of both seizure freedom and visual outcomes following surgery. METHODS: We reviewed manuscripts exploring surgical resection for drug-resistant OLE published between January 1990 and June 2015 on PubMed. Seizure freedom rates were analyzed and potential predictors were evaluated with separate meta-analyses. Postoperative visual outcomes were also examined. RESULTS: We identified 27 case series comprising 584 patients with greater than 1 yr of follow-up. Postoperative seizure freedom (Engel class I outcome) was observed in 65% of patients, and was significantly predicted by age less than 18 yr (odds ratio [OR] 1.54, 95% confidence interval [CI] 1.13-2.18), focal lesion on pathological analysis (OR 2.08, 95% CI 1.58-2.89), and abnormal preoperative magnetic resonance imaging (OR 3.24, 95% 2.03-6.55). Of these patients, 175 also had visual outcomes reported with 57% demonstrating some degree of visual decline following surgery. We did not find any relationship between postoperative visual and seizure outcomes. CONCLUSION: Surgical resection for OLE is associated with favorable outcomes with nearly two-thirds of patients achieving postoperative seizure freedom. However, patients must be counseled regarding the risk of visual decline following surgery.
BACKGROUND:Occipital lobe epilepsy (OLE) is an uncommon but debilitating focal epilepsy syndrome with seizures often refractory to medical management. While surgical resection has proven a viable treatment, previous studies examining postoperative seizure freedom rates are limited by small sample size and patient heterogeneity, thus exhibiting significant variability in their results. OBJECTIVE: To review the medical literature on OLE so as to investigate rates and predictors of both seizure freedom and visual outcomes following surgery. METHODS: We reviewed manuscripts exploring surgical resection for drug-resistant OLE published between January 1990 and June 2015 on PubMed. Seizure freedom rates were analyzed and potential predictors were evaluated with separate meta-analyses. Postoperative visual outcomes were also examined. RESULTS: We identified 27 case series comprising 584 patients with greater than 1 yr of follow-up. Postoperative seizure freedom (Engel class I outcome) was observed in 65% of patients, and was significantly predicted by age less than 18 yr (odds ratio [OR] 1.54, 95% confidence interval [CI] 1.13-2.18), focal lesion on pathological analysis (OR 2.08, 95% CI 1.58-2.89), and abnormal preoperative magnetic resonance imaging (OR 3.24, 95% 2.03-6.55). Of these patients, 175 also had visual outcomes reported with 57% demonstrating some degree of visual decline following surgery. We did not find any relationship between postoperative visual and seizure outcomes. CONCLUSION: Surgical resection for OLE is associated with favorable outcomes with nearly two-thirds of patients achieving postoperative seizure freedom. However, patients must be counseled regarding the risk of visual decline following surgery.
Authors: N Foldvary; B Nashold; E Mascha; E A Thompson; N Lee; J O McNamara; D V Lewis; J S Luther; A H Friedman; R A Radtke Journal: Neurology Date: 2000-02-08 Impact factor: 9.910
Authors: Dario J Englot; Kunal P Raygor; Annette M Molinaro; Paul A Garcia; Robert C Knowlton; Kurtis I Auguste; Edward F Chang Journal: Neurosurgery Date: 2014-12 Impact factor: 4.654
Authors: Dario J Englot; Stephen T Magill; Seunggu J Han; Edward F Chang; Mitchel S Berger; Michael W McDermott Journal: J Neurosurg Date: 2015-12-04 Impact factor: 5.115
Authors: Jung Ju Lee; Sang Kun Lee; Seo-Young Lee; Kyung-Il Park; Dong Wook Kim; Dong Soo Lee; Chun Kee Chung; Hyeon Woo Nam Journal: Seizure Date: 2008-03-10 Impact factor: 3.184
Authors: Lara Jehi; Marcia Morita-Sherman; Thomas E Love; Fabrice Bartolomei; William Bingaman; Kees Braun; Robyn M Busch; John Duncan; Walter J Hader; Guoming Luan; John D Rolston; Stephan Schuele; Laura Tassi; Sumeet Vadera; Shehryar Sheikh; Imad Najm; Amir Arain; Justin Bingaman; Beate Diehl; Jane de Tisi; Matea Rados; Pieter Van Eijsden; Sandra Wahby; Xiongfei Wang; Samuel Wiebe Journal: Ann Neurol Date: 2021-10-14 Impact factor: 11.274
Authors: Pablo Barbero Aznarez; Marta Pastor Cabeza; Ana Sofia Alvarez Quintana; Monica Lara-Almunia; Julio Albisua Sanchez Journal: Surg Neurol Int Date: 2020-08-01
Authors: Vejay N Vakharia; John S Duncan; Juri-Alexander Witt; Christian E Elger; Richard Staba; Jerome Engel Journal: Ann Neurol Date: 2018-04-10 Impact factor: 10.422